Treatment Planning Evaluation and Optimization Should Be Biologically and Not Dose/volume Based

Overview

Journal Med Phys

Specialty Biophysics

Date 2015 Jul 2

PMID 26127027

Citations 8

Authors

Joseph O Deasy

Charles S Mayo

Colin G Orton

Affiliations

Soon will be listed here.

Citing Articles

Data Science Opportunities To Improve Radiotherapy Planning and Clinical Decision Making.

Deasy J Semin Radiat Oncol. 2024; 34(4):379-394.

PMID: 39271273 PMC: 11698470. DOI: 10.1016/j.semradonc.2024.07.012.

Normal Tissue Risk Estimation Using Biological Knowledge-Based Fuzzy Logic in Volumetric Modulated Arc Therapy of Prostate Cancer: Rectum.

Patnaikuni S, Saini S, Chandola R, Chandrakar P, Chaudhary V J Med Phys. 2022; 47(2):126-135.

PMID: 36212203 PMC: 9543004. DOI: 10.4103/jmp.jmp_91_21.

Task-based image quality assessment in radiation therapy: initial characterization and demonstration with computer-simulation study.

Dolly S, Lou Y, Anastasio M, Li H Phys Med Biol. 2019; 64(14):145020.

PMID: 31252422 PMC: 7371446. DOI: 10.1088/1361-6560/ab2dc5.

An extended dose-volume model in high dose-rate brachytherapy - Using mean-tail-dose to reduce tumor underdosage.

Moren B, Larsson T, Carlsson Tedgren A Med Phys. 2019; 46(6):2556-2566.

PMID: 30972758 PMC: 6852298. DOI: 10.1002/mp.13533.

Incorporating big data into treatment plan evaluation: Development of statistical DVH metrics and visualization dashboards.

Mayo C, Yao J, Eisbruch A, Balter J, Litzenberg D, Matuszak M Adv Radiat Oncol. 2017; 2(3):503-514.

PMID: 29114619 PMC: 5605288. DOI: 10.1016/j.adro.2017.04.005.

References

Deasy J, Niemierko A, Herbert D, Yan D, Jackson A, Ten Haken R . Methodological issues in radiation dose-volume outcome analyses: summary of a joint AAPM/NIH workshop. Med Phys. 2002; 29(9):2109-27. DOI: 10.1118/1.1501473. View

Kong F, Pan C, Eisbruch A, Ten Haken R . Physical models and simpler dosimetric descriptors of radiation late toxicity. Semin Radiat Oncol. 2007; 17(2):108-20. DOI: 10.1016/j.semradonc.2006.11.007. View

Christianen M, Schilstra C, Beetz I, Muijs C, Chouvalova O, Burlage F . Predictive modelling for swallowing dysfunction after primary (chemo)radiation: results of a prospective observational study. Radiother Oncol. 2011; 105(1):107-14. DOI: 10.1016/j.radonc.2011.08.009. View

Nazem-Zadeh M, Chapman C, Chenevert T, Lawrence T, Ten Haken R, Tsien C . Response-driven imaging biomarkers for predicting radiation necrosis of the brain. Phys Med Biol. 2014; 59(10):2535-47. PMC: 4084934. DOI: 10.1088/0031-9155/59/10/2535. View

Cella L, Palma G, Deasy J, Oh J, Liuzzi R, DAvino V . Complication probability models for radiation-induced heart valvular dysfunction: do heart-lung interactions play a role?. PLoS One. 2014; 9(10):e111753. PMC: 4216137. DOI: 10.1371/journal.pone.0111753. View

Jeong J, Shoghi K, Deasy J . Modelling the interplay between hypoxia and proliferation in radiotherapy tumour response. Phys Med Biol. 2013; 58(14):4897-919. PMC: 4784425. DOI: 10.1088/0031-9155/58/14/4897. View

Uzan J, Nahum A . Radiobiologically guided optimisation of the prescription dose and fractionation scheme in radiotherapy using BioSuite. Br J Radiol. 2012; 85(1017):1279-86. PMC: 3487060. DOI: 10.1259/bjr/20476567. View

El Naqa I, Pater P, Seuntjens J . Monte Carlo role in radiobiological modelling of radiotherapy outcomes. Phys Med Biol. 2012; 57(11):R75-97. DOI: 10.1088/0031-9155/57/11/R75. View

Li X, Alber M, Deasy J, Jackson A, Ken Jee K, Marks L . The use and QA of biologically related models for treatment planning: short report of the TG-166 of the therapy physics committee of the AAPM. Med Phys. 2012; 39(3):1386-409. DOI: 10.1118/1.3685447. View

10.

Chi A, Tome W, Fowler J, Komaki R, Nguyen N, Mehta M . Stereotactic body radiation therapy in non-small-cell lung cancer: linking radiobiological modeling and clinical outcome. Am J Clin Oncol. 2010; 34(4):432-41. DOI: 10.1097/COC.0b013e3181df4b3f. View

11.

Partridge M, Ramos M, Sardaro A, Brada M . Dose escalation for non-small cell lung cancer: analysis and modelling of published literature. Radiother Oncol. 2011; 99(1):6-11. DOI: 10.1016/j.radonc.2011.02.014. View

12.

Tucker S, Dong L, Bosch W, Michalski J, Winter K, Mohan R . Late rectal toxicity on RTOG 94-06: analysis using a mixture Lyman model. Int J Radiat Oncol Biol Phys. 2010; 78(4):1253-60. PMC: 2963659. DOI: 10.1016/j.ijrobp.2010.01.069. View

13.

Bentzen S, Constine L, Deasy J, Eisbruch A, Jackson A, Marks L . Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): an introduction to the scientific issues. Int J Radiat Oncol Biol Phys. 2010; 76(3 Suppl):S3-9. PMC: 3431964. DOI: 10.1016/j.ijrobp.2009.09.040. View

14.

Deasy J, Bentzen S, Jackson A, Ten Haken R, Yorke E, Constine L . Improving normal tissue complication probability models: the need to adopt a "data-pooling" culture. Int J Radiat Oncol Biol Phys. 2010; 76(3 Suppl):S151-4. PMC: 2854162. DOI: 10.1016/j.ijrobp.2009.06.094. View

15.

Fenwick J, Nahum A, Malik Z, Eswar C, Hatton M, Laurence V . Escalation and intensification of radiotherapy for stage III non-small cell lung cancer: opportunities for treatment improvement. Clin Oncol (R Coll Radiol). 2009; 21(4):343-60. DOI: 10.1016/j.clon.2008.12.011. View

16.

Tucker S, Li M, Xu T, Gomez D, Yuan X, Yu J . Incorporating single-nucleotide polymorphisms into the Lyman model to improve prediction of radiation pneumonitis. Int J Radiat Oncol Biol Phys. 2012; 85(1):251-7. PMC: 3521878. DOI: 10.1016/j.ijrobp.2012.02.021. View